![Olivier Saidi](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Olivier Saidi
Plus aucun poste en cours
Profil
Olivier Saidi is Chief Technology Officer of Aureon Laboratories, Inc.
Anciens postes connus de Olivier Saidi
Sociétés | Poste | Fin |
---|---|---|
Aureon Biosciences, Inc.
![]() Aureon Biosciences, Inc. BiotechnologyHealth Technology Aureon Biosciences, Inc. designs and develops prognostic tests. The company’s prognostic tests include Prostate Px, which assists physicians as they counsel patients on the range of possible treatment options, as well as the patient’s probability of disease recurrence, disease progression and Post-Op Px, a prognostic test to provide patients and their physicians with information about treatment options. The company was founded by Robert H. Singer, Charles M. Cohen, Jonathan Edelson, Olivier Saidi and Carlos Cordón-Cardó in 2001 and is headquartered in Yonkers, NY. | Fondateur | - |
Expériences
Fonctions occupées
Sociétés liées
Entreprise privées | 1 |
---|---|
Aureon Biosciences, Inc.
![]() Aureon Biosciences, Inc. BiotechnologyHealth Technology Aureon Biosciences, Inc. designs and develops prognostic tests. The company’s prognostic tests include Prostate Px, which assists physicians as they counsel patients on the range of possible treatment options, as well as the patient’s probability of disease recurrence, disease progression and Post-Op Px, a prognostic test to provide patients and their physicians with information about treatment options. The company was founded by Robert H. Singer, Charles M. Cohen, Jonathan Edelson, Olivier Saidi and Carlos Cordón-Cardó in 2001 and is headquartered in Yonkers, NY. | Health Technology |